Modulation Therapeutics, Inc.
1 clinical trials · Sponsor
◉ Watch Modulation Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Targeted Alpha Particle Radiotherapy for Metastatic Uveal Melanoma (NCT05496686) | Modulation Therapeutics, Inc. | 2022-07-21 |
Track Modulation Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.